7-130273115-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001869.3(CPA2):c.424G>T(p.Gly142Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000152 in 1,613,884 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001869.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPA2 | NM_001869.3 | c.424G>T | p.Gly142Cys | missense_variant | 5/11 | ENST00000222481.9 | NP_001860.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPA2 | ENST00000222481.9 | c.424G>T | p.Gly142Cys | missense_variant | 5/11 | 1 | NM_001869.3 | ENSP00000222481 | P1 | |
CPA2 | ENST00000480781.5 | n.441G>T | non_coding_transcript_exon_variant | 5/5 | 2 | |||||
CPA2 | ENST00000487259.5 | n.439G>T | non_coding_transcript_exon_variant | 5/7 | 2 | |||||
CPA2 | ENST00000416698.1 | c.418G>T | p.Gly140Cys | missense_variant, NMD_transcript_variant | 5/8 | 5 | ENSP00000395582 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000636 AC: 16AN: 251484Hom.: 0 AF XY: 0.0000809 AC XY: 11AN XY: 135918
GnomAD4 exome AF: 0.000162 AC: 237AN: 1461714Hom.: 1 Cov.: 30 AF XY: 0.000147 AC XY: 107AN XY: 727198
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2022 | The c.424G>T (p.G142C) alteration is located in exon 5 (coding exon 5) of the CPA2 gene. This alteration results from a G to T substitution at nucleotide position 424, causing the glycine (G) at amino acid position 142 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at